Cargando…

A Novel Hydrodynamic Injection Mouse Model of HBV Genotype C for the Study of HBV Biology and the Anti-Viral Activity of Lamivudine

BACKGROUND: Absence of an immunocompetent mouse model of persistent hepatitis B virus (HBV) infection has hindered the research of HBV infection and the development of antiviral medications. OBJECTIVES: In the present study, we aimed to develop a novel HBV genotype C mouse model by hydrodynamic inje...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiumei, Liu, Guangze, Chen, Meijuan, Yang, Yang, Xie, Yong, Kong, Xiangping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867405/ https://www.ncbi.nlm.nih.gov/pubmed/27195013 http://dx.doi.org/10.5812/hepatmon.34420

Ejemplares similares

Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China
por: Gu, Lijun, et al.
Publicado: (2015)

The dose of HBV genome contained plasmid has a great impact on HBV persistence in hydrodynamic injection mouse model
por: Li, Lei, et al.
Publicado: (2017)

T cell--associated immunoregulation and antiviral effect of oxymatrine in hydrodynamic injection HBV mouse model
por: Sang, Xiuxiu, et al.
Publicado: (2017)

Inhibition of hepatitis B virus (HBV) gene expression and replication by HBx gene silencing in a hydrodynamic injection mouse model with a new clone of HBV genotype B
por: Li, Lei, et al.
Publicado: (2013)

Lamivudine treatment for severe acute HBV hepatitis
por: Lisotti, Andrea, et al.
Publicado: (2008)

HBV Genotype B/C and Response to Lamivudine Therapy: A Systematic Review
por: Chen, Xiu-Li, et al.
Publicado: (2013)

Immunosuppressive Drugs Modulate the Replication of Hepatitis B Virus (HBV) in a Hydrodynamic Injection Mouse Model
por: Wang, Junzhong, et al.
Publicado: (2014)

Establishment of drug-resistant HBV small-animal models by hydrodynamic injection
por: Cheng, Junjun, et al.
Publicado: (2014)

Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa
por: Stewart, Balint, et al.
Publicado: (2011)

The doses of plasmid backbone plays a major role in determining the HBV clearance in hydrodynamic injection mouse model
por: Wang, Xian, et al.
Publicado: (2018)

Molecular epidemical characteristics of Lamivudine resistance mutations of HBV in southern China
por: Li, Si-Yue, et al.
Publicado: (2011)

Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis
por: Luo, Aoran, et al.
Publicado: (2018)

IL-33 Inhibits Hepatitis B Virus through Its Receptor ST2 in Hydrodynamic HBV Mouse Model
por: Gao, Xiuzhu, et al.
Publicado: (2020)

Evaluation of adefovir & lamivudine in chronic hepatitis B: Correlation with HBV viral kinetic, hepatic-necro inflammation & fibrosis
por: Pradeep, Kumar S, et al.
Publicado: (2011)

HBV Genotypic Variability in Cuba
por: Loureiro, Carmen L., et al.
Publicado: (2015)

Distribution of HBV genotypes in Poland
por: Świderska, Magdalena, et al.
Publicado: (2015)

Enrichment of Ly6C(hi) monocytes by multiple GM-CSF injections with HBV vaccine contributes to viral clearance in a HBV mouse model
por: Zhao, Weidong, et al.
Publicado: (2017)

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
por: Bihl, Florian, et al.
Publicado: (2015)

Long-Term Hepatitis B Virus (HBV) Response to Lamivudine-Containing Highly Active Antiretroviral Therapy in HIV-HBV Co-Infected Patients in Thailand
por: Khamduang, Woottichai, et al.
Publicado: (2012)

Correlations of HBV Genotypes, Mutations Affecting HBeAg Expression and HBeAg/ anti-HBe Status in HBV Carriers
por: Lim, Chee Kent, et al.
Publicado: (2006)

Prevalence and Genotyping of Torque Teno Virus in HBV/HIV and Chronic HBV Patients in Iran
por: Najafimemar, Zahra, et al.
Publicado: (2018)

Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients
por: Nakamuta, Makoto, et al.
Publicado: (2007)

Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy
por: Costantini, Andrea, et al.
Publicado: (2011)

Hepatitis B Virus (HBV) Genotype Mixtures, Viral Load, and Liver Damage in HBV Patients Co-infected With Human Immunodeficiency Virus
por: Jose-Abrego, Alexis, et al.
Publicado: (2021)

Commentary on: A study of genotype, mutants and nucleotide sequence of HBV in Pakistan: Genotype, mutants, and nucleotide sequence of HBV
por: Jazayeri, Seyed Mohammad
Publicado: (2011)

HBV‐RNA Co‐amplification May Influence HBV DNA Viral Load Determination
por: Maasoumy, Benjamin, et al.
Publicado: (2020)

PreC and C Regions of Woodchuck Hepatitis Virus Facilitate Persistent Expression of Surface Antigen of Chimeric WHV-HBV Virus in the Hydrodynamic Injection BALB/c Mouse Model
por: Wu, Weimin, et al.
Publicado: (2017)

Single-virion sequencing of lamivudine-treated HBV populations reveal population evolution dynamics and demographic history
por: Zhu, Yuan O., et al.
Publicado: (2017)

Different types of viral-host junction found in HBV integration breakpoints in HBV-infected patients
por: Ruan, Peng, et al.
Publicado: (2019)

HBV and HCV genotypes distribution on the territory of Belarus
por: Gasich, EL, et al.
Publicado: (2012)

Clinical and Therapeutical Importance of HBV genotyping in Romania
por: Constantinescu, I, et al.
Publicado: (2008)

Impact of targeted vaccination on HBV genotypes in Amsterdam
por: Bruisten, S., et al.
Publicado: (2006)

Genotyping and sero-virological characterization of hepatitis B virus (HBV) in blood donors, Southern Ethiopia
por: Ambachew, Henock, et al.
Publicado: (2018)

MicroRNAs Associated With HBV Infection And HBV-related HCC
por: Xie, Kun-Lin, et al.
Publicado: (2014)

Risk of Hepatitis B Virus (HBV) Reactivation in Patients with Immune-Mediated Inflammatory Diseases Receiving Biologics: Focus on the Timing of Biologics after Anti-HBV Treatment
por: Ahn, Soo Min, et al.
Publicado: (2022)

Disproportionate Distribution of HBV Genotypes A and D and the Recombinant Genotype D/E in the High and Low HBV Endemic Regions of Uganda: A Wake-Up Call for Regional Specific HBV Management
por: Kafeero, Hussein Mukasa, et al.
Publicado: (2022)

Structural features in common of HBV and HIV-1 resistance against chirally-distinct nucleoside analogues entecavir and lamivudine
por: Yasutake, Yoshiaki, et al.
Publicado: (2020)

Post-translational Modification Control of HBV Biological Processes
por: Yang, Fan
Publicado: (2018)

Proteomic and transcriptomic studies of HBV-associated liver fibrosis of an AAV-HBV-infected mouse model
por: Kan, Fangming, et al.
Publicado: (2017)

Epigenetic regulation of HBV-specific tumor-infiltrating T cells in HBV-related HCC
por: You, Maojun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ekq8g1iisrnkusun88v48ttg7b